Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

BACKGROUND: A tubeless, on-body automated insulin delivery (AID) system (Omnipod 5 Automated Insulin Delivery System) demonstrated improved glycated hemoglobin A1c levels and increased time in range (70 mg/dL to 180 mg/dL) for both adults and children with type 1 diabetes in a 13-week multicenter, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Biskupiak, Joseph E, Ramos, Mafalda, Levy, Carol J, Forlenza, Greg, Hopley, Colin, Boyd, Jennifer, Swift, Dan, Lamotte, Mark, Brixner, Diana I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394185/
https://www.ncbi.nlm.nih.gov/pubmed/37133431
http://dx.doi.org/10.18553/jmcp.2023.22331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394185/
https://www.ncbi.nlm.nih.gov/pubmed/37133431
http://dx.doi.org/10.18553/jmcp.2023.22331

Ejemplares similares